This study provides for the first time extensive and well-substantiated evidence that the expression of these receptors in pancreatic cancer can be of predictive value in the responsiveness to the direct tumour growth inhibitory effects IFN-α therapy. Here, IFNA2 is linked to familial pancreatic carcinoma.